The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study
RN Marcus, RD McQuade, WH Carson… - Journal of clinical …, 2008 - journals.lww.com
Nonresponse to one or more antidepressants is common and an important public health
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study
RN Marcus, RD McQuade, WH Carson, D Hennicken… - 2008 - pubmed.ncbi.nlm.nih.gov
Nonresponse to one or more antidepressants is common and an important public health
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …
The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled …
RN Marcus, RD McQuade, WH Carson… - Journal of Clinical …, 2008 - journals.lww.com
Nonresponse to one or more antidepressants is common and an important public health
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …
[PDF][PDF] The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder
RN Marcus, RD McQuade, WH Carson… - Journal of Clinical …, 2008 - academia.edu
Nonresponse to one or more antidepressants is common and an important public health
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …
[引用][C] The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled …
M RN - J Clin Psychopharmacol., 2008 - cir.nii.ac.jp
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder : a
second multicenter, randomized, double-blind, placebo-controlled study | CiNii Research …
second multicenter, randomized, double-blind, placebo-controlled study | CiNii Research …
[引用][C] The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Second Multicenter, Randomized, Double-Blind, Placebo …
RN MARCUS, RD MCQUADE… - Journal of clinical …, 2008 - pascal-francis.inist.fr
The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder :
A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study CNRS Inist …
A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study CNRS Inist …
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A second multicenter, randomized, double-blind, placebo-controlled study
RN Marcus, RD McQuade… - Journal of …, 2008 - utsouthwestern.elsevierpure.com
Nonresponse to one or more antidepressants is common and an important public health
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
RN Marcus, RD McQuade, WH Carson… - Journal of Clinical …, 2008 - europepmc.org
A comment on this article appears in" Aripiprazole in refractory depression?" J Clin
Psychopharmacol. 2009 Feb; 29 (1): 90-1; author reply 92-3. A comment on this article …
Psychopharmacol. 2009 Feb; 29 (1): 90-1; author reply 92-3. A comment on this article …
[引用][C] The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled …
RN MARCUS - J Clin Psychopharmacol, 2008 - cir.nii.ac.jp
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder : a
second multicenter, randomized, double-blind, placebo-controlled study | CiNii Research CiNii …
second multicenter, randomized, double-blind, placebo-controlled study | CiNii Research CiNii …
[PDF][PDF] The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder
RN Marcus, RD McQuade, WH Carson… - Journal of Clinical …, 2008 - academia.edu
Nonresponse to one or more antidepressants is common and an important public health
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …
problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to …